CD48 and diabetic kidney disease: The expression of CXCL6, CD48, C1QB, and COL6A3 was higher in diabetic nephropathy patients than in normal controls, indicating that their expression is closely related to disease progression, so these key genes may be potential new therapeutic targets for diabetic nephropathy.